Public lecture explores treatments for MS
The debilitating, progressive disease Multiple Sclerosis (MS) and its current and future treatment is the subject of a free public lecture being held at the University of Greenwich at Medway on Wednesday, April 21.
The lecturer is Dr Laurence Harbige, a Reader at the School of Science at the University of Greenwich, who has worked on the discovery and development of new treatments for MS, which affects up to three million sufferers worldwide.
Dr Harbige teaches undergraduate and postgraduate courses in biological, nutritional and biomedical sciences.
He said: “At the moment there is no cure for MS, a disease which blights so many people’s lives. I and my colleague at the University of Greenwich, Dr Mike Leach, have been investigating the role of neuroprotective agents in MS, which has led us to forming a university spin-out company to develop our research further.
“In my lecture I will be describing MS and exploring the rationale for new treatments. Drug treatment has been targeted in two areas of MS, firstly immune-inflammatory modulation and secondly, neuroprotection.”
The free public lecture Multiple Sclerosis: What is it? And how can we treat it? is being held in the Pembroke Building on the university’s Medway Campus at Chatham Maritime from 6.30pm on Wednesday, April 21. Although admission is free, places should be reserved by emailing science-public-lectures@gre.ac.uk or calling 020 8331 9800.
Ends
To find out more about science courses at the University of Greenwich visit www.greenwich.ac.uk or call 0800 005 006.
For interview opportunities, please contact:
University of Greenwich Public Relations
020 8331 9420
Delphine Houlton or Georgette McCready
Maxim
01892 513033